应用人工智能技术诊治肝脏疾病研究进展

doi:10.3969/j.issn.1672-5069.2023.02.036

摘要/Abstract

摘要： 目的人工智能(AI)在很多领域得到了广泛的应用,在医学领域中,AI也发挥越来越多的作用。本文主要就应用AI技术在肝脏疾病诊断、治疗和预后评估方面的研究进展作一综述,旨在提高临床医生对AI诊疗技术的认识,从而为肝病的诊治提供更为有效的决策手段。本文还对AI技术在未来肝脏疾病诊治领域的前景进行了展望。

关键词: 病毒性肝炎, 肝硬化, 肝功能衰竭, 人工智能, 诊治

Abstract: Objective At present, the artificial intelligence (AI) has been widely used in many fields, and it also applied in medical diagnosis and treatment. In this paper, we mainly reviewed the AI research on the diagnosis, management and prognosis of patients with in liver diseases, in order to provide more effective measures. Finally, the future development of AI in the field of liver disease study is prospected.

Key words: Viral hepatitis, Cirrhosis, Liver failure, Artificial intelligence, Management

吴鹏, 高柳村, 汤善宏. 应用人工智能技术诊治肝脏疾病研究进展[J]. 实用肝脏病杂志, 2023, 26(2): 293-296.

Wu Peng, Gao Liucun, Tang Shanhong. Artificial intelligence in the diagnosis and treatment of patients with liver diseases[J]. Journal of Practical Hepatology, 2023, 26(2): 293-296.

参考文献

[1] Krishna AB, Tanveer A, Bhagirath PV, et al. Role of artificial intelligence in diagnostic oral pathology-A modern approach. J Oral Maxillofac Pathol, 2020, 24(1): 152-156.
[2] Ahn JC, Connell A, Simonetto DA, et al. Application of artificial intelligence for the diagnosis and treatment of liver diseases. Hepatology, 2021, 73(6): 2546-2563.
[3] Spann A, Yasodhara A, Kang J, et al. Applying machine learning in liver disease and transplantation: A comprehensive review. Hepatology, 2020, 71(3): 1093-1105.
[4] Li H, Yan L, Shi Y, et al. Hepatitis B virus infection: Overview. Adv Exp Med Biol, 2020, 1179: 1-16.
[5] Khan S, Ullah R, Khan A, et al. Analysis of hepatitis B virus infection in blood sera using Raman spectroscopy and machine learning. Photodiagnosis Photodyn Ther, 2018, 23: 89-93.
[6] Tong D, Chen C, Zhang J, et al. Application of Raman spectroscopy in the detection of hepatitis B virus infection. Photodiagnosis Photodyn Ther, 2019, 28: 248-252.
[7] Jennison E, PateL J, Scorletti E, et al. Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J, 2019, 95(1124): 314-322.
[8] Cao W, An X, Cong L, et al. Application of deep learning in quantitative analysis of 2-dimensional ultrasound imaging of nonalcoholic fatty liver disease. J Ultrasound Med, 2020, 39(1): 51-59.
[9] Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology, 2002, 123(3): 745-750.
[10] Canbay A, Kalsch J, Neumann U, et al. Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective. PLoS One, 2019, 14(3): e0214436.
[11] Yip TC, Ma AJ, Wong VW, et al. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. Aliment Pharmacol Ther, 2017, 46(4): 447-456.
[12] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol, 2019, 70(1): 151-171.
[13] Myera RP, Benhamou Y, Imbert-Bismut F, et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS, 2003, 17(5): 721-725.
[14] Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68, 276 biopsies. J Hepatol, 1986, 2(2): 165-173.
[15] Lee JH, Joo I, Kang TW, et al. Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network. Eur Radiol, 2020, 30(2): 1264-1273.
[16] Wei R, Wang J, Wang X, et al. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine, 2018, 35: 124-132.
[17] Banerjee R, Das A, Ghoshal UC, et al. Predicting mortality in patients with cirrhosis of liver with application of neural network technology. J Gastroenterol Hepatol, 2003, 18(9): 1054-1060.
[18] Marozas M, Zykus R, Sakalauskas A, et al. Noninvasive evaluation of portal hypertension using a supervised learning technique. J Healthc Eng, 2017, 2017: 6183714.
[19] Hong WD, Zhu QH, Huang ZM, et al. Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol, 2009, 9: 11.
[20] Dong TS, Kalani A, Aby ES, et al. Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices. Clin Gastroenterol Hepatol, 2019, 17(9): 1894-1901.
[21] Wang X, Shen C, Yang J, et al. Alpha-fetoprotein as a predictive marker for patients with hepatitis B-related acute-on-chronic liver failure. Can J Gastroenterol Hepatol, 2018, 2018: 1232785.
[22] Garcia MS, Agarwal B, Mookerjee RP, et al. An accurate data preparation approach for the prediction of mortality in ACLF patients using the CANONIC dataset. Annu Int Conf IEEE Eng Med Biol Soc, 2019, 2019: 1371-1377.
[23] Speiser JL, Lee WM, Karvellas CJ, et al. Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PLoS One, 2015, 10(4): e0122929.
[24] Speiser JL, Karvellas CJ, Wolf BJ, et al. Predicting daily outcomes in acetaminophen-induced acute liver failure patients with machine learning techniques. Comput Methods Programs Biomed, 2019, 175: 111-120.
[25] Huang S, Yang J, Fong S, et al. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Lett, 2020, 471: 61-71.
[26] Marya NB, Powers PD, Fujii-Lau L, et al. Application of artificial intelligence using a novel EUS-based convolutional neural network model to identify and distinguish benign and malignant hepatic masses. Gastrointest Endosc, 2021, 93(5): 1121-1130.
[27] Hamm CA, Wang CJ, Savic LJ, et al. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI. Eur Radiol, 2019, 29(7): 3338-3347.
[28] Sun C, Xu A, Liu D, et al. Deep learning-based classification of liver cancer histopathology images using only global labels. IEEE J Biomed Health Inform, 2020, 24(6): 1643-1651.
[29] Saillard C, Schmauch B, Laifa O, et al. Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides. Hepatology, 2020, 72(6): 2000-2013.
[30] Briceno J, Cruz-Ramirez M, Prieto M, et al. Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study. J Hepatol, 2014, 61(5): 1020-1028.
[31] Khosravi B, Pourahmad S, Bahreini A, et al. Five years survival of patients after liver transplantation and its effective factors by neural network and Cox poroportional hazard regression models. Hepat Mon, 2015, 15(9): e25164.
[32] Andres A, Montano-Loza A, Greiner R, et al. A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis. PLoS One, 2018, 13(3): e0193523.
[33] Lee HC, Yoon SB, Yang SM, et al. Prediction of acute kidney injury after liver transplantation: Machine learning approaches vs. Logistic regression model. J Clin Med, 2018, 7(11): 428.
[34] Lv C, Zhang Y, Chen X, et al. New-onset diabetes after liver transplantation and its impact on complications and patient survival. J Diabetes, 2015, 7(6): 881-890.
[35] Bhat V, Tazari M, Watt KD, et al. New-onset diabetes and preexisting diabetes are associated with comparable reduction in long-term survival after liver transplant: A machine learning approach. Mayo Clin Proc, 2018, 93(12): 1794-1802.